Chargement en cours...
Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms
Yearly, ∼2 million people become hepatitis C virus (HCV) infected, resulting in an elevated lifetime risk for severe liver-related chronic illnesses. Characterizing epitopes of broadly neutralizing antibodies (NAbs), such as AR3A, is critical to guide vaccine development. Previously identified alani...
Enregistré dans:
| Publié dans: | J Virol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6364003/ https://ncbi.nlm.nih.gov/pubmed/30487284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01909-18 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|